Literature DB >> 8576785

The heart and vascular changes in hypertension.

G Leonetti1, C Cuspidi.   

Abstract

AIM: To review present knowledge on the causes of cardiovascular changes in hypertension and on the effects of antihypertensive treatment.
BACKGROUND: The clinical manifestations of hypertensive heart disease have changed considerably in recent decades, from predominantly cardiac failure to predominantly left ventricular hypertrophy, which is an independent risk factor for all cardiovascular events. This change parallels the recent development of ultrasonic devices which make it possible to investigate the vessels as well as the heart. These devices have shown that there are different types of cardiac remodeling, which are associated with different hemodynamic profiles. TREATMENT OF CARDIOVASCULAR REMODELING: Recent studies have shown that antihypertensive treatment, both pharmacological and non-pharmacological, can significantly reduce left ventricular hypertrophy in hypertensive patients without jeopardizing the hemodynamic balance. However, hypertensive vessel disease has been less extensively investigated, with many studies concentrating on the carotid arteries. There appears to be a correlation between cardiac and carotid artery changes but so far there is no information on the effects of the antihypertensive treatment on the carotid alterations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8576785     DOI: 10.1097/00004872-199508001-00005

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

1.  Fragmented QRS complexes are associated with increased left ventricular mass in patients with essential hypertension.

Authors:  Hasan Kadi; Ayşe Kevser; Ahmet Ozturk; Fatih Koc; Koksal Ceyhan
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-07-30       Impact factor: 1.468

2.  Early Changes in Atrial Electromechanical Coupling in Patients with Hypertension: Assessment by Tissue Doppler Imaging.

Authors:  Burcak Kilickiran Avci; Oyku Gulmez; Guclu Donmez; Seckin Pehlivanoglu
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

Review 3.  Angiotensin II receptor blockers and cardiovascular protection: focus on left ventricular hypertrophy regression and atrial fibrillation prevention.

Authors:  Cesare Cuspidi; Francesca Negri; Alberto Zanchetti
Journal:  Vasc Health Risk Manag       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.